Pancreatic Exocrine Insufficiency

• FDA approval · 2024-02-28
  FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)

  FDA approved a supplemental application for PERTZYE (pancrelipase) submitted by Digestive Care, Inc.

• FDA approval · 2022-10-21
  FDA Approved: VIOKACE — Supplemental Application (Aimmune Therapeutics, Inc.)

  The FDA approved a supplemental application for Viokace (pancrelipase) by Aimmune Therapeutics, Inc.